Hecht, A., Doll, S., Nowak, D., Lengfelder, E., Weiß, C., Hofmann, W., & Nolte, F. (2017). Validation of a molecular risk score for prognosis of patients with acute promyelocytic Leukemia treated with all-trans retinoic acid and chemotherapy-containing regimens. Clinical lymphoma, myeloma & leukemia, 17(12), . https://doi.org/10.1016/j.clml.2017.08.095
Chicago Style (17th ed.) CitationHecht, Anna, Seraphina Doll, Daniel Nowak, Eva Lengfelder, Christel Weiß, Wolf-Karsten Hofmann, and Florian Nolte. "Validation of a Molecular Risk Score for Prognosis of Patients with Acute Promyelocytic Leukemia Treated with All-trans Retinoic Acid and Chemotherapy-containing Regimens." Clinical Lymphoma, Myeloma & Leukemia 17, no. 12 (2017). https://doi.org/10.1016/j.clml.2017.08.095.
MLA (9th ed.) CitationHecht, Anna, et al. "Validation of a Molecular Risk Score for Prognosis of Patients with Acute Promyelocytic Leukemia Treated with All-trans Retinoic Acid and Chemotherapy-containing Regimens." Clinical Lymphoma, Myeloma & Leukemia, vol. 17, no. 12, 2017, https://doi.org/10.1016/j.clml.2017.08.095.